Skip to content

Vaccination
& Aging

Training an Aging Immune System

Our immune system changes with age.
Vaccination becomes more — not less — important.

Aging alters the cells, tissues and signals that drive immune responses. These changes can reduce vaccine responses in some individuals, but vaccination remains a key strategy to prevent infection and serious disease in older adults.

Explore the science →

Why Vaccination Changes With Age

The vaccine is the same challenge. The immune system receiving it has changed.

Fewer naïve T cells

The thymus shrinks with age, reducing naïve T cells and the diversity of the T-cell repertoire.

Altered T-cell function

T cells show changes in activation, proliferation and memory function.

Changes in B-cell immunity

B-cell populations and function change with age, affecting antibody quality and durability.

YOUNGER
IMMUNE SYSTEM

Diverse, responsive.
More naïve cells.

IMMUNE AGING

Fewer naïve cells,
altered function,
more inflammation.

VACCINE RESPONSE

Often reduced, but still protective.
Stronger protection against severe disease.

Altered antigen presentation

Aging affects dendritic cells and other antigen-presenting cells, changing the signals that activate immune responses.

Inflammaging

Persistent low-grade inflammation can change immune coordination and is associated with reduced vaccine responsiveness.

Remodeled immune memory

Previous infections and vaccinations shape the immune repertoire across life.

Immunosenescence + Inflammaging

Two interconnected features of immune aging shape vaccination.

Immunosenescence

Age-associated changes in immune-cell composition and function, including reduced diversity, altered naïve and memory-cell balance, and impaired immune regulation.

Inflammaging

Persistent low-grade inflammatory activity can alter immune activation, impair coordinated responses and change the inflammatory environment.

Result: A different response to vaccination

  • Weaker responses in some individuals
  • Slower or altered immune activation
  • Potentially lower antibody responses
  • Altered cellular immunity
  • Potentially shorter duration of protection

What Happens After Vaccination?

The pathway remains intact — but aging can influence every step.

1. Antigen recognition

Vaccine antigens enter the body and activate innate immune cells and antigen-presenting cells.

2. Antigen presentation

Dendritic cells process antigens and activate T cells, bridging innate and adaptive immunity.

3. T-cell activation

Antigen-specific CD4+ and CD8+ T-cell responses develop.

4. B-cell activation

Activated B cells proliferate and undergo differentiation into antibody-producing plasma cells.

5. Antibodies and memory

Protective antibodies and long-lived memory B and T cells provide protection against future exposure.

Aging can modify each stepInnate activationAltered signalingAntigen presentationChanges in dendritic cellsT-cell activationReduced naïve T cells, altered functionB-cell responseLower magnitude and quality of antibodiesImmune memoryPotentially shorter duration of protection

A Weaker Response Does Not Mean No Protection

Older adults may generate lower antibody levels or less robust cellular responses than younger adults. Nevertheless, vaccination can still provide meaningful protection, particularly against severe disease, and remains a central preventive strategy for older adults.

Young adultOlder adult≠Stronger responseReduced responsebut still protective

Vaccines remain highly effective at reducing the risk of severe disease, hospitalization and death.

Vaccines Designed With Aging in Mind

The pathogen remains the same. Smarter vaccine design.

Higher Antigen Dose

Increased antigen content can enhance the immune response, addressing immune-system changes in older adults.

More antigen → stronger immune stimulus

Adjuvants

Help activate innate immune responses by stimulating specific pathways and improving the immune response.

Antigen + adjuvant → enhanced activation

Recombinant & Newer Platforms

Recombinant technologies and optimized formulations can improve immune responses without simply increasing the dose.

Newer technologies → optimized responses

Influenza: A Model for Vaccination in Older Adults

Older adults have a high burden of severe influenza, and immune aging can reduce responses to standard vaccines. Enhanced vaccines have been developed to improve protection.

Standard approaches

Standard-dose vaccines

Prior exposure and immune history

Enhanced approaches (preferred for adults ≥65)

Higher dose

Adjuvanted

Recombinant

Vaccines That Matter as We Age

Vaccination helps protect against important severe infections. Recommendations may change, so always check current guidance.

Influenza

High burden of severe disease in older adults; enhanced vaccines can improve immune responses

COVID-19

Older age is a major risk factor for severe disease; staying up to date with recommended vaccination remains important

RSV

Recommended vaccination can reduce severe lower respiratory tract disease

Pneumococcal disease

Recommended for adults 50+; some earlier depending on conditions; helps prevent serious pneumococcal disease

Shingles (herpes zoster)

Recommended beginning at age 50; helps prevent shingles and postherpetic neuralgia

Chronological Age Is Not Immune Age

Two people can be the same age but have different immune profiles.

Age 70

Different immune history.
Different inflammatory profile.
Potentially different vaccine response.

Age 70

Different immune-cell repertoire.
Different immune regulation.
Different vaccine response.

Immune aging is heterogeneous

Genetics, chronic infections, medications, health and lifestyle can influence immune function. Chronological age is useful, but does not capture every individual’s immune profile.

Can We Improve Vaccine Responses During Aging?

A rapidly developing area of immunology.

Established strategies (in current use)

Higher antigen dose

Adjuvants

Optimized vaccine design

Newer vaccine platforms

Research and emerging approaches

Alternative delivery strategies

Systems vaccinology

Biomarkers of vaccine response

Interventions targeting immune aging

The Goal Is Not Just More Antibodies

Vaccines induce immunity in multiple dimensions.

Antibody quantity

Antibody quality

Neutralization breadth

Memory B cells

CD4+ T-cell responses

CD8+ T-cell responses

Duration of immune memory

Protection against severe disease

Healthy Aging Includes Vaccination

Vaccination is a part of healthy aging — protecting against severe infections while supporting a more resilient immune system. Combine vaccination with healthy lifestyle choices and management of chronic conditions.

Take care of your ImmAge. →

Prevent severe infections

Reduce complications

Preserve independence

Support healthy aging

Selected sources and references

Artwork illustrates the main mechanisms schematically; molecular sizes, colors and distances are not literal.